, EBITDA was Bt55,721mn, increasing 7.1% YoY with an EBITDA margin (excluding equipment rental) of 46.2%, compared to 44.7% in 9M17 and continue to expect full year margin in the range of 45-47%. Net profit
granted by the Securities and Exchange Commission) in the range of 321,470,000 Baht to 373,510,00 Baht. As of 6 November 2019, the Company has an investment in YLP in the amount of 170,000,000 Baht. Basis
business and the growth of associates company, Singer Thailand. This has an outstanding performance growth. In addition, the company can plan operations, reduce operating costs to get through the range of
การ อนุญาตให้ออกและเสนอขายหุ้นกูท่ี้มีอนุพนัธ์แฝง แบบ 69-SP (ส่วนท่ี 1 : แบบ 69-SP-1) สามารถเลือกยืน่แบบแสดงรายการขอ้มูล โดยระบุขอ้มูลดงัต่อไปน้ี เป็นช่วง (range) ขอ้มูลตวัเลขสูงสุด (maximum) หรือ ขอ้
formation. Hence, the NESDB has cut down its growth forecast for the Thai economy in 2023 to the range of 2.5%-3.0% from the previous forecast of the range of 2.7%-3.7%, which the supporting factors still
million comparing to the net profit of Baht 1 million and Baht 50 million, respectively, in the same period last year. During this pandemic period, the Company has carefully managed the situation in all
%. Delivered FY20 performance in-line with guidance from well-managed cost Overall FY20 performance tracked in- line with all guidance. Core serviced revenue of Bt129,594mn declined -5.1%YoY vs guidance of low
, society and environment, by having meeting and tracking the risk management results, to find out that they are controlled and managed in the acceptable levels. From the following reasons concluding that the
have managed to drive productivity and delivered our services with better efficiency in the use of resources. Gross Profit As a combined result of improved revenue and reduced cost of services, we booked
performance. The backlog was around 10% of the total sales that lead to less risk under cost fluctuations. The Company has also managed the risk for exchange rate by forward contract. Please be informed